Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator
--------------------------------------------------------------------
Source: CNBC
Published: 2026-04-01 19:47 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Europe, Economy & Finance, Financial Markets, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Novo Nordisk rose as much as 4% after England's drug price regulator recommended the use of its best-selling drug Wegovy to prevent heart attacks and strokes.
--------------------------------------------------------------------